doxazosin and prazosin

doxazosin has been researched along with prazosin in 337 studies

Research

Studies (337)

TimeframeStudies, this research(%)All Research%
pre-1990130 (38.58)18.7374
1990's120 (35.61)18.2507
2000's54 (16.02)29.6817
2010's28 (8.31)24.3611
2020's5 (1.48)2.80

Authors

AuthorsStudies
Campbell, SF; Davey, MJ; Hardstone, JD; Lewis, BN; Palmer, MJ1
Bondinell, WE; Hieble, JP; Ruffolo, RR1
Ballard, S; Blagg, J; Fox, D; Kenny, B1
Topliss, JG; Yoshida, F1
Pedretti, A; Testa, B; Villa, L; Vistoli, G1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Kinsella, GK; Rodriguez, F; Rozas, I; Watson, GW1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH1
Sen, S; Sinha, N1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cilia, A; Maestri, V; Minarini, A; Naldi, M; Nicolini, B; Poggesi, E; Pruccoli, L; Rosini, M; Simoni, E; Tarozzi, A1
Bobba, V; Geldenhuys, WJ; Idippily, N; Petty, A; Su, B; Wang, B; Zhong, B1
Heinzl, S1
Marwood, JF; Stokes, GS; Tierney, G1
Johnston, H; Marwood, JF; Monaghan, JC; Okoro, EO; Stokes, GS1
Feurle, GE1
Charuel, C; Comby, P; Monro, AM1
Babamoto, KS; Hirokawa, WT1
Agabiti-Rosei, E; Beschi, M; Calebich, S; Castellano, M; Muiesan, G; Muiesan, ML; Rizzoni, D; Zulli, R1
Foxall, TL; Nicolosi, RJ; Shwaery, GT; Stucchi, AF; Wong, SS1
Leren, P2
Draaijer, P; Gladziwa, U; Kooman, JP; Leunissen, KM; Peltenburg, HG; Struyker-Boudier, HA; van Bortel, LM; van Hooff, JP; Wijnen, JA1
Jansen van't Land, C; van der Laan, JW1
Donnelly, R; Elliott, HL; Howie, CA; Meredith, PA; Reid, JL1
Kelly, JG; Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP1
Bodansky, HJ1
Daly, L; Devlin, JG; McLaughlin, B1
Bak, M; Christensen, S; Lomholt, N; Petersen, JS; Shalmi, M1
de Planque, BA1
Barlage, U; Englert, RG1
Chakko, S; DiBianco, R; Emmanuel, G; Marlon, A; Parker, JO; Singh, JB; Tanser, PH1
Kaplan, NM; Khoury, AF1
Marwood, J; Stokes, G; Tierney, G3
Abildgaard, U; Christensen, S; Petersen, JS; Shalmi, M1
Colagrande, F; Jackman, GP; Louis, WJ1
McInnes, GT1
Gagało, I; Szreder, Z1
Elsegood, CL; Mackintosh, VS; Redgrave, TG1
Branzi, A; Galiè, N; Limonetti, P; Magnani, B; Passarelli, P1
Durham, SK; Kowala, MC; Nicolosi, RJ; Nunnari, JJ1
Brown, MJ; Dickerson, JE1
Jarry, H; Leonhardt, S; Wuttke, W1
Donnelly, R; Elliott, HL; Howie, CA; Reid, JL; Sumner, DJ1
Birkenhäger, JC; Jansen, H1
Grong, K; Hexeberg, E; Lekven, J; Myking, OL; Olweus, J; Westby, J1
Pool, JL2
Fauchald, P; Holme, I; Rugstad, HE; Stokke, HP1
Langdon, CG1
Naber, FB1
Daae, L; Talseth, T; Westlie, L2
Taylor, SH4
Wessels, F1
Fukiyama, K; Iimura, O; Ijichi, H; Inagaki, Y; Ishii, M; Kaneko, Y; Omae, T; Yagi, S; Yamada, K; Yoshinaga, K1
Maslowski, AH1
Fonseca, R; Marshall, D; Silva, H1
Bonnet, G1
Harmse, DP1
Manos, J1
Corral, JL; López, NC; Pecorelli, A; Rincón, LA; Terán, VD1
Fonseca, R; López, B; Lugo de Franco, V; Medina, O; Monsalve, P; Ostojich, K; Pérez Acuña, F; Torres, N; Vera, O1
Catalano, M; Libretti, A1
Miura, Y; Watanabe, M; Yoshinaga, K1
Armas de Hernandez, MJ; Armas Padilla, MC; Barragan, O; Boada Boada, JJ; Carvajal, AR; Guerrero Pajuelo, J; Hernandez Hernandez, R; Roa, E1
Armas de Hernandez, MJ; Armas Padilla, MC; Barragan, O; Boada Boada, JJ; Carvajal, AR; Guerrero Pajuelo, JR; Hernandez Hernandez, R1
Colina-Chourio, JA; Godoy-Godoy, N; Oliveros-Palacios, MC1
Crepaldi, G; D'Angelo, A; Nosadini, R1
Feher, MD1
Lehtonen, A1
Brusletto, B; Daae, LN; Holme, I; Kierulf, P; Syvertsen, JO; Westheim, A2
Boman, K; Jansson, JH; Johansson, B; Nilsson, TK1
Brinchmann-Hansen, O; Myhre, K1
Donnelly, R; Elliott, HL; Meredith, PA; Reid, JL2
Lund-Johansen, P; Omvik, P1
Baumann, M; Lepor, H; Shapiro, E1
Lindgren, B1
Birkeland, S; Grong, K; Kvitting, P; Lekven, J; Westby, J2
Lenz, ML; Pool, JL; Taylor, AA1
Maclean, D; McDevitt, DG1
Elkeles, RS; Feher, MD; Gelding, S; Henderson, AD; Poulter, C; Richmond, W; Sever, PS; Wadsworth, J1
Bornmyr, S; De Pedis, G; Hulthén, UL; Lecerof, H; Lilja, B1
Groppelli, A; Mancia, G; Omboni, S; Parati, G1
Daae, LN; Talseth, T; Westlie, L1
Dewhurst, AG; Honeywell, R; Oliver, RM; Renwick, AG; Upward, JW; Waller, DG1
Aursnes, I1
Christensen, CC; Dathan, R; Dean, S; Searle, M; Westheim, A1
Jansen, H1
Brown, MJ1
Oliver, RM; Waller, DG1
Anderton, JL; Notghi, A1
Amery, A; Fagard, R; Lijnen, P; Staessen, J2
Buzzaccarini, F; Casolino, P; Giusto, M; Mozzato, MG; Pessina, AC; Rubino, N; Semplicini, A; Serena, L; Valle, R1
Calvete, J; Hayes, R; Sever, PS; Thom, S1
Jie, K; Timmermans, PB; van Brummelen, P; van Zwieten, PA; Vermey, P4
Kaneko, Y; Miyajima, E; Miyakawa, T; Shionoiri, H; Takagi, N; Umemura, S; Yasuda, G; Yoshimura, H1
Baggen, RG; Jansen, H1
Chichester, CO; Rodgers, RL1
Swindell, AC; Woodside, WF1
Miller, NE; Nanjee, MN1
Hughes, A; Inkpen, P; Sever, P1
Anavekar, SN; Conway, EL; Drummer, OH; Howes, LG; Jarrott, B; Louis, WJ; McNeil, JJ; Workman, B1
D'Eletto, RD; Javitt, NB1
Hoover, KW; Krupp, MN; Valentine, JJ1
Swindell, AC; Valentine, JJ2
Karge, WH; Kowala, MC; Nicolosi, RJ; Weiner, EJ1
Ontko, JA; Woodside, WF2
Kowala, MC; Nicolosi, RJ1
Baggen, MG; Birkenhäger, JC; Jansen, H; Lammers, R1
Dzau, VJ1
Amery, A; Fagard, R; Lijnen, P; Lissens, W; Staessen, J1
Bevegård, S; Ekenvall, L; Etzell, BM; Lindblad, LE1
Bautovich, GJ; Fletcher, PJ; Gillin, AG; Horvath, JS; Hutton, BF; Tiller, DJ1
Conway, EL; Drummer, OH; Howes, LG; Louis, WJ; McNeil, JJ; Meng, L; Raymond, K1
Ames, RP; Chrysant, SG; Gonzalez, F; Schnaper, HW; Spann, S; Velasquez, MT1
Ose, L1
Ganzinger, U1
Bruschke, AV; Mauve, I; Mohanlal, RW; van der Laarse, A; van der Valk, L1
Hughes, AD; Martin, GN; Mulvany, MJ; Nielsen, H; Sever, PS; Thom, SM1
Baggen, MG; Birkenhäger, JC; Jansen, H; Lammers, R; Penders, JM1
Ames, RP; Kiyasu, JY1
Davey, MJ1
Nelson, EB; Pool, JL; Taylor, AA1
Biernacki, W; Flenley, DC1
Buzzaccarini, F; Casiglia, E; Casolino, P; Mozzato, MG; Pessina, AC; Rubino, N; Semplicini, A; Serena, L; Valle, R1
Grimm, RH1
Calvete, J; Hayes, R; Martin, G; Sever, P; Thom, S1
Alabaster, VA; Solca, AM1
Leren, TP1
Hamilton, CA; Reid, JL; Vincent, J1
Gaba, DM; Hayward, E; Maze, M1
Elliott, HL; Meredith, PA; Reid, JL; Vincent, J3
Alabaster, VA; Davey, MJ1
Reid, JL; Vincent, J1
Davey, M1
Hayduk, K1
Rosenthal, J3
Cox, DA; Frick, MH; Himanen, P; Huttunen, M; Pitkäjärvi, T; Pörsti, P; Pöyhönen, L; Pyykönen, ML; Reinikainen, P; Salmela, P1
Madsbu, HP; Torvik, D2
Badskjaer, J; Faergeman, O; Jensen, H; Krusell, LR; Ott, P; Storm, TL1
Elliott, HL; Meredith, PA; Reid, JL1
Wilner, KD; Ziegler, MG1
Black, H; Nash, DT; Reeves, RL; Schonfeld, G; Weidler, DJ1
Hayduk, K; Schneider, HT1
Claessens, J; Nelemans, F; Riesen, W; Streulens, Y; Trost, BN; Weidmann, P1
Birkenhäger, WH; de Bos, R; de Leeuw, PW; van Es, PN3
Elliott, HL; Kelman, AW; Meredith, PA; Reid, JL; Vincent, J1
Brogden, RN; Young, RA1
Ekenvall, L; Etzell, BM; Lindblad, LE; Norbeck, O1
van den Hogen, AL1
Guevara, J; Silva, H; Soltero, I; Velasco, M1
Bartels, AC; de Vries, PM; Donker, AJ; Fillastre, JP; Oe, LP; Réveillaud, RJ; van Bronswÿk, H; Zech, P1
Al Awady, M; Castrignano, R; Crepaldi, G; D'Angelo, A; Pati, T; Tronca, R1
Miura, Y; Yoshinaga, K1
Daae, L; Talseth, T; Vatle, S; Westlie, L1
Guerrasio, E; Mazzola, C1
Fioravanti, G; Giorgi, G; Legramante, A; Legramante, JM; Paies, G1
Berger, J; Blumrich, W; Bouzo, H; Brandl, K; Braun, S; Laukaitis, A; Müller, G; Nechwatal, W; Ryba, W; Schreiegg, J1
Lindner, UK; Stafunsky, M; von Manteuffel, GE1
Lee, PS; Sharma, SK; Taylor, SH1
Englert, RG; Mauersberger, H1
Hansson, L1
Birkenhäger, WH; de Leeuw, PW1
Berg, K; Leren, TP1
Cowlishaw, MG; Sharman, JR1
Cussans, NJ; Faulkner, JK; Kaye, B; Reid, JL; Stopher, DA1
Haugland, H; Lund-Johansen, P; Omvik, P1
Frick, MH; Halttunen, P; Himanen, P; Huttunen, M; Pitkäjärvi, T; Pörsti, P; Pöyhönen, L; Pyykönen, ML; Reinikainen, P; Salmela, P1
Baez, MA; Garg, DC; Jallad, NS; Weidler, DJ1
Himanen, P; Lehtonen, A; Marniemi, J; Niittymäki, K; Saraste, M1
Cox, DA; Leader, JP; Milson, JA; Singleton, W1
Bailey, RR; Begg, EJ; Carlson, RV; Cowlishaw, MG; Sharman, JR1
Bailey, RR; Nairn, PL; Walker, RJ1
Caplan, N; Cubeddu, LX; Ferry, D; Fuenmayor, N1
Faulkner, JK; Himanen, P; Karjalainen, U; Saraste, M1
Daae, L; Hjermann, I; Hjortdahl, P; Holme, I; von Krogh, H1
Butty, J; Gordon, D; Whitworth, JA1
Nechwatal, W1
Hosie, J; Scott, MG; Scott, PJ1
Bloomfield, R; Cubeddu, LX; Halperin, A; Klotman, PE; Nelson, EB; Pickering, BI; Pool, JL; Wombolt, DG1
Krusell, LR; Ott, P; Storm, T1
Jackson, G; Lorimer, AR; Pringle, S; Smyth, P1
Conrad, KA; Fagan, TC; Falkner, FC; Lazar, JD; Lee, S; Mackie, MJ; Mayshar, PV; Souhrada, JF1
Fouda, HG; Schneider, RP; Twomey, TM1
Campbell, SF; Davey, MJ1
Ramage, AG1
Ali, FK; Kwa, HY; Timmermans, PB; van Zwieten, PA1
Moulds, RF; Stevens, MJ1
Elliott, HL; McLean, K; Meredith, PA; Reid, JL; Sumner, DJ1
Birkenhäger, WH; de Leeuw, PW; Ligthart, JJ; Smout, AJ1
Downing, OA; Wilson, KA; Wilson, VG1
Hernandez, J; Prichard, BN; Saxton, CA; Singleton, W1
Elliott, HL; Reid, JL; Sumner, DJ1
Ali, FK; Kossen, SP; Timmermans, PB; Van Zwieten, PA1
Brunton, J; Meredith, P; Rubin, PC1
Stockamp, K1
Chalmers, DH; Kenny, BA; Naylor, AM; Philpott, PC1
Dutkiewicz, S; Witeska, A1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG1
Kaplan, SA; Olsson, CA; Soldo, KA1
Dutkiewicz, S; Stepień, K; Witeska, A1
Chapple, CR2
Angeli-Greaves, M; Armas Padilla, MC; Armas-Hernández, MJ; Carvajal, AR; Guerrero Pajuelo, J; Hernández Hernández, R1
Ramage, AG; Wyllie, MG1
Mikami, H1
Chalmers, DH; Kenny, BA; Miller, AM; Naylor, AM; O'Connell, J; Williamson, IJ1
Beevers, DG; Marshall, HJ1
Hatano, A; Lepor, H; Tang, R; Walden, PD1
Crucianelli, M; Giardinà, D; Marucci, G; Massi, M; Melchiorre, C; Polidori, C; Pompei, P1
Frankel, S1
Brune, ME; Buckner, SA; Hancock, AA; Ireland, LM; Katwala, SP; Kerwin, JF; Milicic, I1
Vatz, KA1
Andersson, KE; Lepor, H; Wyllie, MG1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I1
Ikeguchi, E; Kaplan, SA; Santarosa, RP; Te, AE1
Beduschi, MC; Beduschi, R; Oesterling, JE1
Benos, DJ; Bradford, AL; Bubien, JK; Cornwell, T; DuVall, MD; Fuller, CM1
Chung, M; Hilbert, J; Lawrence, V; Phillips, K; Vashi, V1
Kim, SC; Lee, MY; Lim, SW; Seo, KK1
Borkowski, A; Chon, JK; Isaacs, JT; Jacobs, SC; Kyprianou, N; Partin, AW1
Djavan, B; Marberger, M1
Hoffman, RM; Jansen, DJ; Resch, ND1
Eglen, RM; MacLennan, SJ; Martin, GR; Martin, RS; Reynen, PH1
Eglen, RM; MacLennan, SJ; Martin, GR; Reynen, PH1
Clifford, GM; Farmer, RD1
Benning, CM; Kyprianou, N2
Benning, CM; Chon, J; Kyprianou, N1
Caprino, L1
Blanchard, K; Hananel, A; Rutchik, S; Sullivan, J1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD1
Chao, J; Chrischilles, E; Gilden, D; Kreder, KJ; Rubenstein, L; Shah, H1
Akduman, B; Crawford, ED1
Jacobs, SC; Kyprianou, N1
Ambrosioni, E1
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE1
Baykara, M; Ciftcioglu, MA; Emreoglu, I; Erdoğru, T; Gulkesen, KH; Koksal, T; Ozbilim, G; Usta, MF1
Alcaide, C; González-Juanatey, JR; Iglesias, MJ; Lago, F; Piñeiro, R1
Keledjian, K; Kyprianou, N1
Niu, CQ; Ren, LM1
Kyprianou, N1
Gonzalez, CM; McVary, KT1
Romics, I1
Bakshi, M; Ojha, T; Singh, S1
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C1
Kyprianou, N; Tahmatzopoulos, A1
Brown, GA; Sussman, DO1
Ficker, EK; Hammerling, BC; Karle, CA; Katus, HA; Kiehn, J; Kuryshev, YA; Schoels, W; Thomas, D; Wimmer, AB; Wu, K1
Doggrell, SA1
Kyprianou, N; Rowland, RG; Tahmatzopoulos, A1
Dincel, C; Samli, MM1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E1
Basar, H; Basar, MM; Batislam, E; Ferhat, M; Tuglu, D; Yilmaz, E1
Afshari, NA; Schwinn, DA1
Michel, MC; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Someya, A; Suzuki, M; Ukai, M; Watanabe, M; Yanai-Inamura, H; Yuyama, H1
de la Rosette, JJ; Michel, MC1
O'Leary, MP1
Akova, YA; Altan-Yaycioglu, R; Ozkardes, H; Tufan, H; Yaycioglu, O1
Baron, AT; Becker, A; Conner, W; Durbin, EB; Harris, AM; Kimbler, K; Kyprianou, N; Lane, M; Rowland, RG; Warner, BW; Wilson, JM1
Albo, G; Berardi, F; Colabufo, NA; Contino, M; de Rienzo, G; Niso, M; Pagliarulo, A; Pagliarulo, V; Perrone, R1
Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ1
Kitteringham, NR; Macdonald, I; Park, BK; Randle, LE; Sathish, JG; Williams, DP1
Mamalis, N1
Cheng, XR; Hua, CX; Hua, L; Huang, Y; Kang, J; Li, N; Li, YS; Liu, H; Ming, GH; Pang, HM; Wang, L; Wu, Y; Xu, L; Xu, ZM1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ1
Hoyano, Y; Kobayashi, S; Kusama, H; Maruyama, K; Tomiyama, Y; Yamazaki, Y1
Kakumoto, M; Kobayashi, H; Ohnishi, N; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y; Yokoyama, T1
Acharya, SV; Bandgar, TR; Ganesh, HK; Goerge, J; Menon, PS; Shah, NS1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA1
Chen, X; Liu, K; Zhong, D1
Chatziralli, IP; Sergentanis, TN1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H1
Krome, S1
Du, H; He, L; Ren, J; Wang, S1
Casuccio, A; Cillino, G; Cillino, S; Pavone, C; Spitale, E1
Gandhi, HP; Giridhar, R; Naik, PP; Yadav, MR1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW1
Ahmed, S; El Zohny, SA; Mohamed, NA1
Araki, M; Araki, T; Monden, K1
Li, AP; Peng, H; Peng, JD; Zhang, J; Zhou, MQ1
Barkin, J; Berner, T; Diles, D; Franks, B1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C1
Coen, K; Funk, D; Lê, AD; Li, Z; Loughlin, A; Tamadon, S1
Anoopkumar-Dukie, S; Batty, M; Chess-Williams, R; Christie, D; Forbes, A; McDermott, CM; Pugh, R; Rathinam, I; Simmonds, J; Spencer, B; Walker, E1
Belayneh, M; Korownyk, C1
Derayea, SM; Hammad, MA; Mohamed, AA; Mohamed, AI; Omar, MA1
Du, Q; Kong, DZ; Ren, LM; Zhang, PP1
Hammad, MA; Omar, MA; Salman, BI1
Hori, Y; Ohyama, K; Sugiura, M1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ1
Araújo, AV; da Silva, SB; de L Alves, SM; Dos Anjos, JV; Feitosa, SGD; Santos, RCA1
Amorim, AC; Antunes, E; Britto-Júnior, J; Campos, R; da Silva-Filho, WP; De Nucci, G; Fregonesi, A; Monica, FZ; Moraes, MEA; Moraes, MO1
Baldassarri, V; Cicione, A; D'Annunzio, S; DE Nunzio, C; Franco, A; Guarnotta, G; Lombardo, R; Mancini, E; Nacchia, A; Rovesti, LM; Tema, G; Tubaro, A; Voglino, OA1

Reviews

51 review(s) available for doxazosin and prazosin

ArticleYear
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.
    Journal of medicinal chemistry, 1995, Sep-01, Volume: 38, Issue:18

    Topics: Animals; Humans; Molecular Biology; Molecular Structure; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

1995
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Prostatic adenoma: new drugs, new surgical techniques].
    Medizinische Monatsschrift fur Pharmazeuten, 1992, Volume: 15, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androstenes; Azasteroids; Cystoscopes; Doxazosin; Finasteride; Humans; Male; Prazosin; Prostatectomy; Prostatic Hyperplasia; Stents

1992
Doxazosin: a new alpha 1-adrenergic antagonist.
    Clinical pharmacy, 1992, Volume: 11, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Antihypertensive Agents; Doxazosin; Hemodynamics; Humans; Hypertension; Lipids; Prazosin

1992
The cardiovascular effects of alpha-receptor blocking agents.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1992, Volume: 10, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cardiomegaly; Cardiovascular System; Cost-Benefit Analysis; Doxazosin; Humans; Hypertension; Lipids; Prazosin

1992
Alpha-blocker therapy of hypertension. An unfulfilled promise.
    JAMA, 1991, Jul-17, Volume: 266, Issue:3

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Hypertension; Lipids; Prazosin

1991
The value of alpha-blockers in the management of hypertension: a practical view.
    Journal of human hypertension, 1991, Volume: 5, Issue:4

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Blood Pressure; Coronary Disease; Doxazosin; Humans; Hypotension, Orthostatic; Lipids; Posture; Prazosin; Risk Factors; Smoking

1991
Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Clinical Trials as Topic; Coronary Disease; Doxazosin; Humans; Hypertension; Lipids; Prazosin; Prospective Studies; Risk Factors

1991
Efficacy of doxazosin in specific hypertensive patient groups.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Cardiomegaly; Diabetes Mellitus, Type 2; Doxazosin; Humans; Hyperlipidemias; Hypertension; Kidney Failure, Chronic; Lung Diseases, Obstructive; Pheochromocytoma; Prazosin; Smoking; Vascular Diseases

1991
Doxazosin therapy in the treatment of diabetic hypertension.
    American heart journal, 1991, Volume: 121, Issue:4 Pt 2

    Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Doxazosin; Humans; Hypertension; Lipids; Lipoproteins; Prazosin; Risk Factors

1991
New drugs for hypertension--variations on old themes.
    Drug and therapeutics bulletin, 1991, Mar-18, Volume: 29, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dihydropyridines; Doxazosin; Humans; Hypertension; Isradipine; Nifedipine; Prazosin; Verapamil

1991
Efficacy and tolerance of doxazosin: a review.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Blood Pressure; Cholesterol; Double-Blind Method; Doxazosin; Forecasting; Humans; Hypertension; Lipoproteins, HDL; Posture; Prazosin

1990
Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 12

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Blood Pressure; Clonidine; Doxazosin; Humans; Hypertension; Prazosin

1987
Factors influencing the lipid response to selective alpha 1-inhibition.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Diet; Doxazosin; Humans; Hypertension; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins, LDL; Nutritional Status; Prazosin; Species Specificity

1989
[New specialty drugs registered in Austria. Supressin].
    Wiener klinische Wochenschrift, 1989, Oct-27, Volume: 101, Issue:20

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Humans; Hypertension; Prazosin

1989
Clinical pharmacotherapeutics of doxazosin.
    The American journal of medicine, 1989, Aug-16, Volume: 87, Issue:2A

    Topics: Adrenergic alpha-Antagonists; Coronary Disease; Doxazosin; Hemodynamics; Humans; Hypertension; Prazosin; Risk

1989
Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension.
    The American journal of medicine, 1989, Aug-16, Volume: 87, Issue:2A

    Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Hemodynamics; Humans; Hypertension; Muscle, Smooth, Vascular; Prazosin

1989
Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
    The American journal of medicine, 1989, Aug-16, Volume: 87, Issue:2A

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Doxazosin; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins; Prazosin

1989
alpha 1-antagonists in the treatment of hypertension.
    Hypertension (Dallas, Tex. : 1979), 1989, Volume: 13, Issue:5 Suppl

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Blood Pressure; Doxazosin; Humans; Hypertension; Prazosin

1989
Mechanism of alpha blockade for blood pressure control.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Calcium Channel Blockers; Doxazosin; Endothelium; Norepinephrine; Prazosin; Receptors, Adrenergic, alpha

1987
Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Drugs, 1988, Volume: 35, Issue:5

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Clinical Trials as Topic; Dogs; Doxazosin; Hemodynamics; Humans; Hypertension; Kidney; Mice; Prazosin; Rats

1988
Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Coronary Disease; Dose-Response Relationship, Drug; Doxazosin; Hemodynamics; Humans; Hypertension; Lipids; Prazosin; Risk

1988
Implications of doxazosin therapy on risk of coronary heart disease.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Coronary Disease; Doxazosin; Humans; Lipoproteins; Prazosin; Risk

1988
Doxazosin, a case history.
    Drug design and delivery, 1986, Volume: 1, Issue:1

    Topics: Animals; Doxazosin; Humans; Prazosin; Vasodilator Agents

1986
[Therapy of benign prostatic hyperplasia with alpha receptor blockers].
    Der Urologe. Ausg. A, 1995, Volume: 34, Issue:1

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Treatment Outcome; Urinary Bladder Neck Obstruction; Urodynamics

1995
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience.
    European urology, 1996, Volume: 29, Issue:2

    Topics: Adrenergic alpha-Antagonists; Blood Pressure; Clinical Trials as Topic; Doxazosin; Half-Life; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Vasodilation

1996
[Alpha-blocker].
    Nihon rinsho. Japanese journal of clinical medicine, 1995, Volume: 53 Su Pt 1

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Antihypertensive Agents; Diagnosis, Differential; Doxazosin; Humans; Hypertension; Pheochromocytoma; Prazosin

1995
Measures of Proscar, Hytrin, and Cardura side effects.
    Neurourology and urodynamics, 1997, Volume: 16, Issue:1

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia

1997
Prostatic alpha 1-adrenoceptors and uroselectivity.
    The Prostate, 1997, Feb-15, Volume: 30, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Revista clinica espanola, 1997, Volume: 197, Issue:5

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1997
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
    British journal of urology, 1998, Volume: 81 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1998
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist.
    Urology, 1998, Volume: 51, Issue:6

    Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin

1998
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    European urology, 1999, Volume: 36, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Controlled Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Doxazosin; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urologic Diseases

1999
Medical therapy for benign prostatic hyperplasia: a review of the literature.
    European urology, 2000, Volume: 38, Issue:1

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2000
[Drugs for the treatment of benign prostatic hypertrophy].
    Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2000, Volume: 52, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Androgen Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Muscle, Smooth; Plant Extracts; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Serenoa; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urodynamics

2000
Terazosin, doxazosin, and prazosin: current clinical experience.
    Urology, 2001, Volume: 58, Issue:6 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Doxazosin; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha

2001
Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
    Current urology reports, 2000, Volume: 1, Issue:2

    Topics: Adrenergic alpha-Antagonists; Apoptosis; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Tumor Cells, Cultured

2000
Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    The Journal of urology, 2003, Volume: 169, Issue:4

    Topics: Adrenergic alpha-Antagonists; Apoptosis; Doxazosin; Humans; Male; Prazosin; Prostate; Prostatic Hyperplasia; Structure-Activity Relationship; Treatment Outcome; Urinary Bladder Neck Obstruction

2003
The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Current urology reports, 2003, Volume: 4, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Disease Progression; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Treatment Outcome

2003
[Pharmacologic treatment of benign prostatic hyperplasia].
    Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2003
Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    The Prostate, 2004, Apr-01, Volume: 59, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Quinazolines

2004
The role of alpha-blockers in the management of prostate cancer.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin

2004
Treatment and pharmacologic management of BPH in the context of common comorbidities.
    The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome

2006
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].
    Harefuah, 2008, Volume: 147, Issue:6

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2008
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
    Ophthalmology, 2011, Volume: 118, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin

2011
[How effective is finasteride?].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin

2011
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
    European urology, 2016, Volume: 69, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics

2016
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers.
    International journal of molecular sciences, 2016, Aug-16, Volume: 17, Issue:8

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antineoplastic Agents; Doxazosin; Female; Humans; Male; Prazosin; Prostatic Neoplasms

2016
Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers.
    Canadian family physician Medecin de famille canadien, 2016, Volume: 62, Issue:9

    Topics: Adrenergic alpha-Antagonists; Dizziness; Doxazosin; Humans; Hypotension; Lower Urinary Tract Symptoms; Male; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic

2016
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
    The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi

2020

Trials

102 trial(s) available for doxazosin and prazosin

ArticleYear
Increase in serum total angiotensin-converting enzyme activity with enalapril therapy in humans: a controlled trial.
    Clinical and experimental pharmacology & physiology, 1992, Volume: 19, Issue:5

    Topics: Double-Blind Method; Doxazosin; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Prazosin; Renin-Angiotensin System

1992
Doxazosin: a new alpha 1-adrenergic antagonist.
    Clinical pharmacy, 1992, Volume: 11, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Antihypertensive Agents; Doxazosin; Hemodynamics; Humans; Hypertension; Lipids; Prazosin

1992
Doxazosin in the management of hypertensive diabetes--a cautionary note (?).
    Irish journal of medical science, 1992, Volume: 161, Issue:1

    Topics: Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Doxazosin; Humans; Hypertension; Middle Aged; Prazosin

1992
A double-blind comparative study of doxazosin and prazosin when administered with beta-blockers or diuretics.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Netherlands; Prazosin; Risk Factors

1991
The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Time Factors

1991
Doxazosin for the treatment of chronic congestive heart failure: results of a randomized double-blind and placebo-controlled study.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Doxazosin; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quality of Life

1991
[Comparative effects of doxazosin and enalapril in patients with arterial hypertension and exercise-induced acute myocardial ischemia].
    Cardiologia (Rome, Italy), 1991, Volume: 36, Issue:10

    Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Coronary Disease; Doxazosin; Enalapril; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Vasodilator Agents

1991
Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Doxazosin; Drug Synergism; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Prazosin

1991
Vascular pressor responses in treated and untreated essential hypertension.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:2

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Doxazosin; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Peptidyl-Dipeptidase A; Phenylephrine; Prazosin; Reflex; Regional Blood Flow; Renin

1990
Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Blood Pressure; Cholesterol; Coronary Disease; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Norway; Prazosin; Product Surveillance, Postmarketing; Risk Factors; Time Factors

1991
Doxazosin: a study in a cohort of patients with hypertension in general practice--an interim report.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Cohort Studies; Coronary Disease; Doxazosin; England; Family Practice; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Risk Factors; Smoking

1991
An open, noncomparative study of doxazosin in essential hypertension: experience in general practice in The Netherlands.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Coronary Disease; Doxazosin; Family Practice; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Netherlands; Prazosin; Risk Factors

1991
Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Atenolol; Cholesterol; Coronary Disease; Double-Blind Method; Doxazosin; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Norway; Prazosin; Risk Factors; Time Factors

1991
Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Coronary Disease; Double-Blind Method; Doxazosin; Enalapril; Family Practice; Female; Germany, West; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Risk Factors

1991
A double-blind comparative study of doxazosin and prazosin in the treatment of essential hypertension.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin

1991
Clinical experience with doxazosin in general medical practice in New Zealand.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Coronary Disease; Doxazosin; Family Practice; Female; Humans; Hypertension; Lipids; Male; Middle Aged; New Zealand; Prazosin; Product Surveillance, Postmarketing; Risk Factors

1991
Doxazosin in the treatment of essential hypertension in general medical practice in Latin America.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Argentina; Cholesterol; Coronary Disease; Doxazosin; Family Practice; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Risk Factors; Venezuela

1991
A multicenter study of doxazosin in the treatment of essential hypertension in France.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Coronary Disease; Doxazosin; Family Practice; Female; France; Humans; Hypertension; Male; Middle Aged; Prazosin; Risk Factors

1991
Clinical experience with doxazosin in general medical practice in The Netherlands.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Coronary Disease; Doxazosin; Family Practice; Female; Humans; Hypertension; Male; Middle Aged; Netherlands; Prazosin; Risk Factors

1991
A long-term study of doxazosin in the treatment of mild or moderate essential hypertension in general medical practice.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Doxazosin; Drug Therapy, Combination; Family Practice; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Time Factors

1991
Doxazosin in the treatment of mild or moderate essential hypertension: an echocardiographic study.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adult; Antihypertensive Agents; Cardiomegaly; Doxazosin; Echocardiography; Female; Humans; Hypertension; Male; Prazosin

1991
Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cardiomegaly; Cholesterol; Coronary Disease; Doxazosin; Echocardiography; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Risk Factors; Venezuela

1991
Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Coronary Disease; Doxazosin; England; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Risk Factors; Single-Blind Method

1991
A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Doxazosin; Female; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Prazosin; Regional Blood Flow

1991
An evaluation of the efficacy and safety of doxazosin in hypertension associated with renal dysfunction. The Japanese Doxazosin Study Group.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adult; Aged; Antihypertensive Agents; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Male; Middle Aged; Prazosin

1991
Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: an ex vivo study.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Cholesterol; Coronary Disease; Dose-Response Relationship, Drug; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prazosin; Risk Factors; Single-Blind Method; Thromboembolism

1991
Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein.
    The American journal of cardiology, 1991, Jan-15, Volume: 67, Issue:2

    Topics: Adult; Antihypertensive Agents; Double-Blind Method; Doxazosin; Drug Administration Schedule; Female; Humans; Hypertension; Kallikreins; Male; Middle Aged; Natriuresis; Prazosin; Renin-Angiotensin System

1991
Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicenter Study Group.
    American heart journal, 1991, Volume: 121, Issue:4 Pt 2

    Topics: Adult; Antihypertensive Agents; Blood Glucose; Doxazosin; Female; Finland; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged; Prazosin

1991
Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.
    European journal of clinical pharmacology, 1991, Volume: 40, Issue:4

    Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Double-Blind Method; Doxazosin; Female; Fibrinolysis; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Male; Plasminogen Inactivators; Prazosin; Randomized Controlled Trials as Topic; Risk Factors; Tissue Plasminogen Activator

1991
Dose-response clarification in early drug development.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Enalapril; Humans; Hypertension; Nifedipine; Prazosin

1991
Doxazosin in 'resistant' hypertension.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Diuretics; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Prazosin

1990
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Journal of human hypertension, 1990, Volume: 4, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Atenolol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Female; Glucose; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Prazosin

1990
Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Atenolol; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Plethysmography; Prazosin; Skin; Smoking; Thermography; Ultrasonography; Vascular Resistance; Vasoconstriction

1990
Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Atenolol; Blood Pressure; Doxazosin; Heart Rate; Humans; Hypertension; Prazosin; Single-Blind Method; Smoking

1990
Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:5

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Atenolol; Double-Blind Method; Doxazosin; Female; Hemodynamics; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Retrospective Studies; Smoking

1990
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
    European journal of clinical pharmacology, 1990, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Prazosin

1990
Efficacy and tolerance of doxazosin: a review.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Blood Pressure; Cholesterol; Double-Blind Method; Doxazosin; Forecasting; Humans; Hypertension; Lipoproteins, HDL; Posture; Prazosin

1990
A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Cholesterol; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Risk Factors; Time Factors; Triglycerides

1990
An evaluation of the efficacy and safety of doxazosin in the treatment of hypertension associated with renal insufficiency.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Acute Kidney Injury; Adult; Blood Pressure; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Single-Blind Method

1990
Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Methods and findings in experimental and clinical pharmacology, 1990, Volume: 12, Issue:8

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Doxazosin; Drug Administration Schedule; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Regression Analysis

1990
Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Journal of cardiovascular pharmacology, 1988, Volume: 12, Issue:4

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Random Allocation; Regression Analysis

1988
Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:2

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Chemical Analysis; Blood Pressure; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Time Factors

1989
Comparison of doxazosin and atenolol in mild hypertension, and effects on exercise capacity, hemodynamics and left ventricular function.
    The American journal of cardiology, 1989, Apr-15, Volume: 63, Issue:13

    Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Prazosin; Radionuclide Imaging

1989
Effectiveness of doxazosin in systemic hypertension.
    The American journal of cardiology, 1989, Jul-15, Volume: 64, Issue:3

    Topics: Adult; Antihypertensive Agents; Body Weight; Double-Blind Method; Doxazosin; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Male; Multicenter Studies as Topic; Prazosin; Random Allocation; Supination

1989
[New specialty drugs registered in Austria. Supressin].
    Wiener klinische Wochenschrift, 1989, Oct-27, Volume: 101, Issue:20

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Humans; Hypertension; Prazosin

1989
Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
    British journal of clinical pharmacology, 1989, Volume: 28, Issue:5

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Female; Heart Rate; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Norepinephrine; Phenylephrine; Prazosin

1989
Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Lipoproteins; Male; Prazosin; Random Allocation

1989
alpha 1-antagonists in the treatment of hypertension.
    Hypertension (Dallas, Tex. : 1979), 1989, Volume: 13, Issue:5 Suppl

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Blood Pressure; Doxazosin; Humans; Hypertension; Prazosin

1989
Human vascular smooth muscle responses mediated by alpha 2 mechanisms in vivo and in vitro.
    Clinical science (London, England : 1979), 1985, Volume: 68 Suppl 10

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Arteries; Brimonidine Tartrate; Dioxanes; Doxazosin; Forearm; Humans; Idazoxan; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha

1985
Effects of oral antihypertensive agents on blood lipid levels.
    Clinical therapeutics, 1986, Volume: 8, Issue:3

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Pindolol; Prazosin; Prospective Studies; Risk

1986
Efficacy and safety of doxazosin in hypertension therapy.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1987
A multicenter trial of doxazosin in West Germany.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Prazosin

1987
Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Doxazosin; Humans; Hydrochlorothiazide; Hypertension; Lipids; Placebos; Prazosin

1987
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Time Factors

1987
An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1987
Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Prazosin

1987
Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Dopamine beta-Hydroxylase; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Prazosin; Random Allocation; Renal Circulation; Renin; Sympathetic Nervous System; Vascular Resistance

1987
A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Heart Rate; Humans; Hypertension; Lipids; Placebos; Prazosin; Random Allocation

1987
Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Prazosin

1987
Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prazosin; Prospective Studies; Random Allocation

1987
Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Drugs, 1988, Volume: 35, Issue:5

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Clinical Trials as Topic; Dogs; Doxazosin; Hemodynamics; Humans; Hypertension; Kidney; Mice; Prazosin; Rats

1988
A multicenter study of doxazosin in the treatment of severe essential hypertension.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Prazosin

1988
Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Catecholamines; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Pheochromocytoma; Prazosin

1988
Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Coronary Disease; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Disease; Doxazosin; Female; Heart Rate; Humans; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Risk

1988
A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Doxazosin; Electrocardiography; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Nitrendipine; Prazosin

1988
A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Enalapril; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
Alpha-adrenoceptors and the kidney.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1988, Volume: 6, Issue:2

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Hypertension; Kidney; Prazosin; Receptors, Adrenergic, alpha; Renal Circulation; Renin; Yohimbine

1988
A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Kinetics; Lipids; Male; Middle Aged; Prazosin; Random Allocation

1986
Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Random Allocation

1986
Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adult; Aged; Antihypertensive Agents; Body Weight; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation

1986
Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adult; Aged; Antihypertensive Agents; Apolipoproteins; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Prazosin; Random Allocation; Time Factors; Triglycerides

1986
The antihypertensive effects of doxazosin: a clinical overview.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kinetics; Male; Metoprolol; Middle Aged; Nadolol; Prazosin; Propanolamines; Random Allocation; Risk; Triglycerides

1986
Effect of doxazosin on blood pressure and renal haemodynamics of hypertensive patients with renal failure.
    The New Zealand medical journal, 1986, Dec-10, Volume: 99, Issue:815

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Humans; Hypertension, Renal; Male; Middle Aged; Prazosin; Renal Circulation

1986
Clinical pharmacology of doxazosin in patients with essential hypertension.
    Clinical pharmacology and therapeutics, 1987, Volume: 41, Issue:4

    Topics: Adult; Blood Pressure; Blood Proteins; Doxazosin; Female; Half-Life; Heart Rate; Humans; Hypertension; Kinetics; Male; Middle Aged; Prazosin; Random Allocation

1987
The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.
    European journal of clinical pharmacology, 1987, Volume: 31, Issue:6

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Kinetics; Male; Middle Aged; Prazosin; Random Allocation

1987
A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension.
    Acta medica Scandinavica, 1987, Volume: 221, Issue:5

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Time Factors

1987
Acute haemodynamic and hormonal effects of oral doxazosin in normal subjects.
    Clinical and experimental pharmacology & physiology, 1987, Volume: 14, Issue:2

    Topics: Administration, Oral; Adult; Aldosterone; Antihypertensive Agents; Doxazosin; Hemodynamics; Humans; Hydrocortisone; Male; Prazosin; Renin

1987
[Doxazosin and nitrendipine. A double-blind comparative study in patients with mild to moderate hypertension].
    Fortschritte der Medizin, 1987, Nov-30, Volume: 105, Issue:34

    Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Prazosin

1987
A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients.
    European journal of clinical pharmacology, 1988, Volume: 34, Issue:2

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Electrocardiography; Female; Humans; Hypertension; Male; Placebos; Prazosin; Pulse; Random Allocation

1988
Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension.
    American journal of hypertension, 1988, Volume: 1, Issue:2

    Topics: Blood Pressure; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Norepinephrine; Prazosin

1988
24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo.
    European journal of clinical pharmacology, 1988, Volume: 34, Issue:6

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Prazosin

1988
Doxazosin in patients with hypertension.
    European journal of clinical pharmacology, 1988, Volume: 35, Issue:1

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Half-Life; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin

1988
Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline.
    Clinical science (London, England : 1979), 1985, Volume: 68 Suppl 10

    Topics: Adult; Doxazosin; Epinephrine; Forearm; Humans; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Vasoconstriction; Yohimbine

1985
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
    British journal of clinical pharmacology, 1982, Volume: 13, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Heart Rate; Humans; Kinetics; Male; Prazosin; Quinazolines

1982
Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.
    European journal of clinical pharmacology, 1982, Volume: 23, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Posture; Prazosin; Quinazolines; Time Factors

1982
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.
    British journal of clinical pharmacology, 1983, Volume: 15, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Half-Life; Heart Rate; Humans; Kinetics; Male; Phenylephrine; Prazosin; Quinazolines

1983
Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man.
    Journal of cardiovascular pharmacology, 1982, Volume: 4 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Doxazosin; Heart Rate; Humans; Male; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Quinazolines

1982
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (Part One).
    International urology and nephrology, 1995, Volume: 27, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Blood Pressure; Doxazosin; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Treatment Outcome; Urodynamics

1995
Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safety.
    European urology, 1995, Volume: 28, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Doxazosin; Drug Administration Schedule; Humans; Male; Middle Aged; Pilot Projects; Prazosin; Prostatic Hyperplasia; Urodynamics

1995
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (BPH) (Part Two).
    International urology and nephrology, 1995, Volume: 27, Issue:4

    Topics: Acid Phosphatase; Adrenergic alpha-Antagonists; Creatinine; Doxazosin; Humans; Male; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Time Factors

1995
Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    American journal of hypertension, 1996, Volume: 9, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Arteries; Blood Pressure; Cholesterol; Doxazosin; Female; Heart Rate; Humans; Hypertension; In Vitro Techniques; Lipids; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prazosin; Triglycerides

1996
Pharmacokinetic interaction between finasteride and terazosin, but not finasteride and doxazosin.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:11

    Topics: Adrenergic alpha-Antagonists; Adult; Area Under Curve; Doxazosin; Drug Interactions; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Time Factors

1998
[Management of hypertensive patients with left ventricular hypertrophy].
    Presse medicale (Paris, France : 1983), 2002, Volume: 31 Spec No 2

    Topics: Adrenergic alpha-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Echocardiography; Electrocardiography; Enalapril; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Placebos; Prazosin; Prognosis; Prospective Studies; Risk Factors; Time Factors

2002
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
    Urology, 2002, Volume: 60, Issue:4

    Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders

2002
Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5

    Topics: Clinical Trials as Topic; Doxazosin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin

2004
Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders.
    Urologia internationalis, 2004, Volume: 73, Issue:2

    Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Doxazosin; Humans; Male; Middle Aged; Prazosin; Prospective Studies; Prostatic Hyperplasia

2004
The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.
    The Journal of urology, 2005, Volume: 173, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Humans; Male; Middle Aged; Pain Measurement; Prazosin; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Calculi

2005
[Comparison of different drugs on the treatment of benign prostate hyperplasia].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, Jul-15, Volume: 45, Issue:14

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome

2007
[Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2007, Volume: 29, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Doxazosin; Drug Therapy, Combination; Humans; Hypertension; Prazosin; Sulfonamides; Torsemide; Treatment Outcome

2007
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
    Acta medica Okayama, 2013, Volume: 67, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome

2013

Other Studies

189 other study(ies) available for doxazosin and prazosin

ArticleYear
2,4-diamino-6,7-dimethoxyquinazolines. 1. 2-[4-(1,4-benzodioxan-2-ylcarbonyl)piperazin-1-yl] derivatives as alpha 1-adrenoceptor antagonists and antihypertensive agents.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Brain; Dioxanes; Dioxins; Heart Rate; Hypertension; Indicators and Reagents; Models, Molecular; Piperazines; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1987
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
    Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15

    Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Computational approach to the basicity of a series of alpha1-adrenoceptor ligands in aqueous solution.
    Bioorganic & medicinal chemistry, 2007, Apr-15, Volume: 15, Issue:8

    Topics: Chemical Phenomena; Chemistry, Physical; Computational Biology; Databases, Factual; Epinephrine; Guanidine; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Ligands; Molecular Conformation; Norepinephrine; Receptors, Adrenergic, alpha-1; Solutions; Thermodynamics; Vasoconstrictor Agents; Water

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi

2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Quinazoline based α
    European journal of medicinal chemistry, 2017, Aug-18, Volume: 136

    Topics: Adrenergic alpha-1 Receptor Antagonists; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Tumor Cells, Cultured

2017
Design and synthesis of small molecule agonists of EphA2 receptor.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Doxazosin; Drug Design; Ephrin-A2; Humans; Molecular Docking Simulation; Molecular Structure; Receptor, EphA2; Small Molecule Libraries; Structure-Activity Relationship

2018
A study of the interaction between the hypotensive actions of doxazosin and enalaprilat in anaesthetized rats.
    Journal of hypertension, 1992, Volume: 10, Issue:3

    Topics: Anesthesia; Animals; Antihypertensive Agents; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Doxazosin; Drug Evaluation, Preclinical; Drug Interactions; Enalaprilat; Female; Hypertension; Prazosin; Rats; Rats, Inbred Strains; Thiopental

1992
[Doxazosin-induced lupus erythematodes].
    Deutsche medizinische Wochenschrift (1946), 1992, Jan-24, Volume: 117, Issue:4

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Doxazosin; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prazosin

1992
Diurnal exposure profile in rats from dietary administration of a chemical (doxazosin) with a short half-life: interplay of age and diurnal feeding pattern.
    Journal of applied toxicology : JAT, 1992, Volume: 12, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aging; Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Doxazosin; Feeding Behavior; Half-Life; Male; Prazosin; Rats; Rats, Inbred Strains; Time Factors

1992
Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Journal of human hypertension, 1992, Volume: 6, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Diastole; Dose-Response Relationship, Drug; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Organ Size; Prazosin; Renin; Rest; Stress, Physiological; Systole; Time Factors

1992
Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.
    The American journal of pathology, 1992, Volume: 140, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Aortic Diseases; Arteriosclerosis; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Hypercholesterolemia; Lipids; Male; Mesocricetus; Prazosin

1992
Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    Journal of human hypertension, 1992, Volume: 6, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Doxazosin; Drug Administration Schedule; Drug Therapy, Combination; Family Practice; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Osmolar Concentration; Pindolol; Prazosin

1992
Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis.
    Kidney international, 1992, Volume: 41, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Compliance; Doxazosin; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Nitroglycerin; Plethysmography; Prazosin; Reference Values; Renal Dialysis; Time Factors; Valsalva Maneuver; Veins

1992
Chronic infusion of clonidine does not alleviate spontaneous morphine withdrawal symptoms in rats.
    Psychopharmacology, 1992, Volume: 108, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Clonidine; Doxazosin; Drug Implants; Eating; Food; Male; Morphine; Morphine Dependence; Motor Activity; Prazosin; Quinoxalines; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome

1992
Combination of nifedipine and doxazosin in essential hypertension.
    Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:4

    Topics: Aged; Analysis of Variance; Angiotensin II; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Phenylephrine; Prazosin

1992
Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Doxazosin; Drug Therapy, Combination; Enalaprilat; Heart Rate; Hemodynamics; Humans; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Prazosin; Pulmonary Wedge Pressure; Vasodilator Agents; Ventricular Function, Left

1992
Doxazosin: alternative antihypertensive treatment.
    Diabetic medicine : a journal of the British Diabetic Association, 1992, Volume: 9, Issue:6

    Topics: Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Prazosin

1992
Amiloride-sensitive lithium reabsorption during doxazosin-induced blood pressure reduction in rats.
    Clinical science (London, England : 1979), 1991, Volume: 81, Issue:6

    Topics: Absorption; Amiloride; Animals; Antihypertensive Agents; Doxazosin; Female; Glomerular Filtration Rate; Kidney; Lithium; Prazosin; Random Allocation; Rats; Rats, Inbred Strains; Sodium; Urination

1991
New alpha 1-adrenergic blocker offers once-daily dosing.
    Geriatrics, 1991, Volume: 46, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Doxazosin; Humans; Hypertension; Prazosin

1991
Management of coronary heart disease risk factors in hypertensive patients: clinical experience with doxazosin. A symposium. London, England, January 26, 1990. Proceedings.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Antihypertensive Agents; Coronary Disease; Doxazosin; Humans; Hypertension; Prazosin; Risk Factors

1991
Investigations into interactions between doxazosin and enalaprilat at alpha 1-adrenoceptors in anaesthetized rats.
    Clinical and experimental pharmacology & physiology, 1991, Volume: 18, Issue:4

    Topics: Adrenergic alpha-Antagonists; Anesthesia; Angiotensin II; Animals; Desoxycorticosterone; Doxazosin; Drug Interactions; Drug Synergism; Enalaprilat; Female; Phenylephrine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha

1991
Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
    The Journal of pharmacology and experimental therapeutics, 1991, Jul-01, Volume: 258, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Drug Interactions; Female; Furosemide; Infusions, Intravenous; Kidney Function Tests; Kidney Tubules, Proximal; Lithium; Prazosin; Rats; Rats, Inbred Strains; Sodium

1991
Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin.
    Journal of chromatography, 1991, May-03, Volume: 566, Issue:1

    Topics: Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Humans; Hydrogen-Ion Concentration; Methanol; Prazosin; Propranolol

1991
The effect of doxazosin, urapidil and indoramin pretreatment on fever produced by E. coli lipopolysaccharide in rabbits.
    General pharmacology, 1991, Volume: 22, Issue:5

    Topics: Adrenergic alpha-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature Regulation; Doxazosin; Escherichia coli; Female; Fever; Indoramin; Lipopolysaccharides; Male; Piperazines; Prazosin; Rabbits

1991
Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats.
    Clinical and experimental pharmacology & physiology, 1991, Volume: 18, Issue:11

    Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic Antagonists; Angiotensin II; Animals; Cholesterol Esters; Doxazosin; Emulsions; Fenoterol; Isoproterenol; Lipoprotein Lipase; Lipoproteins; Male; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic; Triglycerides

1991
Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters.
    Atherosclerosis, 1991, Volume: 91, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Cholesterol; Cholestyramine Resin; Cricetinae; Doxazosin; Heart Rate; Hyperlipidemias; Lipoproteins; Male; Mesocricetus; Prazosin

1991
A norepinephrine-dependent mechanism in the preoptic/anterior hypothalamic area but not in the mediobasal hypothalamus is involved in the regulation of the gonadotropin-releasing hormone pulse generator in ovariectomized rats.
    Neuroendocrinology, 1990, Volume: 51, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Doxazosin; Female; Hydroxyindoleacetic Acid; Hypothalamus; Hypothalamus, Anterior; Hypothalamus, Middle; Luteinizing Hormone; Norepinephrine; Ovary; Pituitary Hormone-Releasing Hormones; Prazosin; Preoptic Area; Rats; Secretory Rate

1990
Interactions between enalaprilat and doxazosin at rat tail artery alpha 1-adrenoceptors.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Arteries; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Doxazosin; Drug Interactions; Enalaprilat; Male; Phenylephrine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Renin; Tail

1991
Effects of the selective alpha 1-antagonist, doxazosin, on hepatic lipid levels and metabolism in the golden hamster.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Body Weight; Cholesterol; Cricetinae; Doxazosin; Hydroxymethylglutaryl CoA Reductases; Lipase; Lipid Metabolism; Lipoprotein Lipase; Liver; Male; Mesocricetus; Microsomes, Liver; Prazosin; Triglycerides

1991
Blood flow regulation during acute regional ischemia in feline hearts: importance of postjunctional alpha 1- and alpha 2-adrenoceptors.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Catecholamines; Cats; Coronary Circulation; Coronary Disease; Doxazosin; Heart; Male; Myocardium; Oxygen Consumption; Perfusion; Prazosin; Receptors, Adrenergic, alpha; Vascular Resistance

1991
The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adult; Antihypertensive Agents; Blood Platelets; Dose-Response Relationship, Drug; Doxazosin; Female; Humans; Hypertension; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prazosin

1991
Doxazosin for treatment of hypertension.
    The Medical letter on drugs and therapeutics, 1991, Feb-22, Volume: 33, Issue:838

    Topics: Antihypertensive Agents; Blood Glucose; Doxazosin; Humans; Hypertension; Lipids; Prazosin

1991
Diabetes mellitus and hypertension: a physiologic basis for a rational therapeutic approach.
    American heart journal, 1991, Volume: 121, Issue:4 Pt 2

    Topics: Antihypertensive Agents; Biological Transport; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Doxazosin; Drug Evaluation; Humans; Hydrogen; Hypertension; Lithium; Prazosin; Sodium

1991
[The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Apr-10, Volume: 111, Issue:9

    Topics: Adult; Blood Pressure; Doxazosin; Fibrinogen; Humans; Hypertension; Lipids; Middle Aged; Plasminogen Inactivators; Prazosin; Smoking

1991
Prolonged photostress macular recovery after reduced blood pressure.
    Aviation, space, and environmental medicine, 1991, Volume: 62, Issue:6

    Topics: Adaptation, Physiological; Adult; Aerospace Medicine; Antihypertensive Agents; Blood Pressure; Doxazosin; Humans; Hypertension; Intraocular Pressure; Lighting; Macula Lutea; Male; Middle Aged; Prazosin; Reaction Time; Reference Values; Stress, Physiological

1991
The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol.
    Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:4

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzeneacetamides; Calcium Channel Blockers; Carbazoles; Carvedilol; Doxazosin; Female; Guanidines; Hemodynamics; Humans; Indoles; Labetalol; Male; Middle Aged; Nisoldipine; Pinacidil; Potassium Channels; Prazosin; Propanolamines; Propylamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Tiapamil Hydrochloride

1990
Binding and functional properties of doxazosin in the human prostate adenoma and canine brain.
    The Prostate, 1990, Volume: 16, Issue:1

    Topics: Adenoma; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Brain; Dogs; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Prazosin; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, alpha

1990
The cost-benefit approach to pricing new medicines: doxazosin versus beta-blocker treatment in Sweden.
    American heart journal, 1990, Volume: 119, Issue:3 Pt 2

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cost-Benefit Analysis; Doxazosin; Humans; Hypertension; Lipoproteins, HDL; Male; Middle Aged; Prazosin; Sweden

1990
Regional perfusion in hearts with acute coronary artery occlusion and subsequent beta 2- and alpha 1-adrenergic blockade.
    Clinical physiology (Oxford, England), 1990, Volume: 10, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cats; Coronary Circulation; Coronary Disease; Doxazosin; Drug Interactions; Hemodynamics; Male; Myocardium; Oxygen Consumption; Prazosin; Propanolamines; Renal Circulation; Renin

1990
Hypertension, coronary risk and alpha-blockade.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Coronary Disease; Doxazosin; Humans; Hypertension; Prazosin; Risk Factors

1990
Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Doxazosin; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, VLDL; Male; Prazosin; Receptors, LDL; Risk Factors; Triglycerides; Up-Regulation

1990
Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Lipids; Male; Middle Aged; Plasminogen Inactivators; Prazosin; Smoking

1990
The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:4

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Female; Glomerular Filtration Rate; Half-Life; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Prazosin; Renal Circulation

1990
[Doxazosin--therapeutic advantages in hypertension].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1990, Apr-10, Volume: 110, Issue:10

    Topics: Doxazosin; Humans; Hypertension; Prazosin

1990
The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Animals; Atenolol; Cholesterol, Dietary; Cholesterol, HDL; Cricetinae; Doxazosin; Humans; Lipoprotein Lipase; Mesocricetus; Prazosin; Propranolol; Time Factors; Triglycerides

1990
Doxazosin in renal impairment.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Administration, Oral; Doxazosin; Drug Administration Schedule; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Prazosin; Renal Circulation

1990
Pfizer introduces new antihypertensive.
    Nephrology news & issues, 1990, Volume: 4, Issue:12

    Topics: Antihypertensive Agents; Doxazosin; Humans; Prazosin

1990
[Doxazosin for the treatment of arterial hypertension].
    Cardiologia (Rome, Italy), 1990, Volume: 35, Issue:11

    Topics: Adult; Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Doxazosin; Drug Administration Schedule; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Posture; Prazosin

1990
In vivo and in vitro studies of alpha 2-adrenoceptor responses in human vascular smooth muscle.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 6

    Topics: Adult; Animals; Arm; Brimonidine Tartrate; Dioxanes; Dioxins; Doxazosin; Epinephrine; Humans; Idazoxan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha; Regional Blood Flow; Vasomotor System

1985
Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans.
    Journal of cardiovascular pharmacology, 1987, Volume: 9, Issue:4

    Topics: Blood Pressure; Doxazosin; Heart Rate; Humans; Injections, Intra-Arterial; Male; Norepinephrine; Prazosin; Receptors, Adrenergic, alpha; Regional Blood Flow; Tyramine; Yohimbine

1987
Antihypertensive effects and pharmacokinetics of single and consecutive administration of doxazosin in patients with mild to moderate essential hypertension.
    Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:1

    Topics: Adult; Aldosterone; Blood Pressure; Catecholamines; Creatinine; Doxazosin; Electrolytes; Female; Heart Rate; Humans; Hypertension; Kinetics; Male; Middle Aged; Prazosin; Renin

1987
Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 9

    Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Animals; Cholesterol, Dietary; Doxazosin; Insulin; Lipids; Lipoprotein Lipase; Liver; Male; Myocardium; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Thyroid Hormones

1987
Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 9

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Collagen; Dose-Response Relationship, Drug; Doxazosin; Hypertension; Lipids; Male; Muscle, Smooth, Vascular; Prazosin; Rats; Rats, Inbred SHR; Time Factors

1987
Effects of alpha 1-inhibition on lipid metabolism in the rat.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 9

    Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol, Dietary; Dietary Carbohydrates; Doxazosin; Food Deprivation; Lipids; Male; Prazosin; Rats; Rats, Inbred Strains; Sucrose

1987
Studies with doxazosin on the saturable binding of 125I-LDL by liver in normocholesterolemic mice.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 9

    Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Dose-Response Relationship, Drug; Doxazosin; Female; Iodine Radioisotopes; Lipoproteins, LDL; Liver; Mice; Mice, Inbred Strains; Prazosin; Receptors, LDL; Triglycerides

1987
Action of dopamine on isolated human saphenous veins.
    Journal of cardiovascular pharmacology, 1988, Volume: 11, Issue:3

    Topics: Aged; Dopamine; Doxazosin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Saphenous Vein; Vasodilator Agents; Yohimbine

1988
Effect of doxazosin on cholesterol synthesis in cell culture.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Cells, Cultured; Cholesterol; Cholesterol Esters; Deuterium; Doxazosin; Fibroblasts; Liver Neoplasms, Experimental; Prazosin; Receptors, LDL; Tumor Cells, Cultured

1989
Mechanisms of selective alpha1-inhibition in lipid metabolism. Role of doxazosin. Proceedings of an international workshop. Puerto Rico, April 16, 1988.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Lipid Metabolism; Prazosin

1989
Effects of doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdJ mouse.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Doxazosin; Lipase; Lipoprotein Lipase; Liver; Male; Mice; Mice, Inbred Strains; Prazosin; Purinones; Triglycerides

1989
Interactions of doxazosin with insulin or glucagon in the ob/ob mouse.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: 3-Hydroxybutyric Acid; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Cholesterol; Doxazosin; Fatty Acids, Nonesterified; Glucagon; Glycerol; Hydroxybutyrates; Insulin; Lactates; Lactic Acid; Male; Mice; Mice, Obese; Prazosin; Triglycerides

1989
Serum lipids, lipoproteins, hemodynamics, and hemostasis in doxazosin-treated monkeys.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Apolipoproteins B; Disease Models, Animal; Doxazosin; Hemodynamics; Hemostasis; Hypercholesterolemia; Lipids; Lipoproteins; Macaca fascicularis; Male; Prazosin

1989
Influence of doxazosin on lipid transport in rats and hamsters.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Biological Transport; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Doxazosin; Food, Formulated; Lipid Metabolism; Liver; Male; Prazosin; Rats; Species Specificity; Triglycerides

1989
Regulation of triglyceride mobilization in isolated hepatocytes by dibutyryl cyclic AMP and epinephrine.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Bucladesine; Chloroquine; Doxazosin; Epinephrine; Epoxy Compounds; Fatty Acids; Lipid Mobilization; Liver; Male; Prazosin; Propranolol; Rats; Triglycerides

1989
Effect of doxazosin on plasma lipids and atherogenesis: a preliminary report.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Doxazosin; Female; Foam Cells; Gerbillinae; Heart Rate; Male; Prazosin; Triglycerides

1989
Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxazosin; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Mesocricetus; Norepinephrine; Prazosin; Propranolol; Thyroid Hormones; Triglycerides

1989
Adrenoceptors in Raynaud's disease.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:6

    Topics: Adult; Azepines; Doxazosin; Female; Fingers; Humans; Isoproterenol; Male; Middle Aged; Norepinephrine; Prazosin; Raynaud Disease; Receptors, Adrenergic; Regional Blood Flow; Skin

1989
Does alpha 1-adrenergic blockade influence regional blood flow regulation in hearts with coronary artery occlusion?
    Clinical physiology (Oxford, England), 1989, Volume: 9, Issue:2

    Topics: Animals; Atenolol; Cats; Coronary Circulation; Coronary Disease; Doxazosin; Female; Male; Prazosin; Vasodilator Agents

1989
Single-dose and steady-state pharmacokinetics of doxazosin given in combination with chlorothiazide to hypertensive subjects.
    Clinical pharmacokinetics, 1989, Volume: 16, Issue:6

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chlorothiazide; Doxazosin; Female; Half-Life; Humans; Hypertension; Male; Middle Aged; Prazosin

1989
[Marketing of Carduran].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1989, Jun-20, Volume: 109, Issue:17-18

    Topics: Catalogs, Drug as Topic; Doxazosin; Humans; Prazosin

1989
Delayed recovery of homogeneous perfusion distribution in isolated rat heart after vasodilatation induced by alpha 1 adrenoceptor blockade during postischaemic reperfusion.
    Cardiovascular research, 1989, Volume: 23, Issue:11

    Topics: Animals; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Doxazosin; L-Lactate Dehydrogenase; Myocardial Reperfusion; Myocardium; Prazosin; Rats; Rats, Inbred Strains; Stroke Volume; Vasodilator Agents

1989
Postjunctional alpha 2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels.
    British journal of pharmacology, 1989, Volume: 97, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Arteries; Azepines; Brimonidine Tartrate; Doxazosin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Norepinephrine; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha; Regional Blood Flow; Skin; Vascular Resistance; Vasoconstriction; Veins; Yohimbine

1989
Inhibition of hepatic cholesterol synthesis by the alpha 1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster.
    Life sciences, 1989, Volume: 44, Issue:15

    Topics: Acetates; Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxazosin; Hypercholesterolemia; Lipoproteins; Liver; Male; Mesocricetus; Prazosin; Reference Values; Triglycerides

1989
Alpha-blockade for hypertension: indifferent past, uncertain future.
    Lancet (London, England), 1989, May-13, Volume: 1, Issue:8646

    Topics: Antihypertensive Agents; Coronary Disease; Doxazosin; Drug Evaluation; Humans; Hypertension; Prazosin; Prognosis

1989
An in vitro study of interactions between doxazosin and enalaprilat at vascular alpha 1-adrenoceptors.
    Clinical and experimental pharmacology & physiology, 1989, Volume: 16, Issue:4

    Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Doxazosin; Drug Interactions; Enalapril; Enalaprilat; In Vitro Techniques; Male; Phenylephrine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Renin-Angiotensin System

1989
Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies. Proceedings of a symposium. Naples, Florida, October 13 to 16, 1988.
    The American journal of medicine, 1989, Aug-16, Volume: 87, Issue:2A

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Doxazosin; Humans; Hypertension; Prazosin

1989
Doxazosin, a new alpha-1-antagonist drug, controls hypertension without causing airways obstruction in asthma and COPD.
    Journal of human hypertension, 1989, Volume: 3, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Asthma; Blood Pressure; Doxazosin; Female; Forced Expiratory Volume; Humans; Hypertension; Lung Diseases, Obstructive; Male; Middle Aged; Peak Expiratory Flow Rate; Prazosin; Prospective Studies; Pulmonary Ventilation; Respiration; Single-Blind Method

1989
Plethysmographic effects of doxazosin in essential hypertensive patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1989, Volume: 7, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Evaluation; Female; Humans; Hypertension; Leg; Male; Middle Aged; Plethysmography; Prazosin; Regional Blood Flow

1989
Lack of differential inhibition by nifedipine of pressor responses induced by alpha 1- and alpha 2-adrenoceptor agonists and by angiotensin II in anaesthetized cats.
    Clinical science (London, England : 1979), 1985, Volume: 68 Suppl 10

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Blood Pressure; Cats; Doxazosin; Male; Muscle, Smooth, Vascular; Nifedipine; Nordefrin; Phenylephrine; Prazosin; Vasoconstriction; Yohimbine

1985
Doxazosin increases low density lipoprotein receptor activity.
    Acta pharmacologica et toxicologica, 1985, Volume: 56, Issue:3

    Topics: Adrenergic alpha-Antagonists; Cell Line; Cells, Cultured; Child, Preschool; Doxazosin; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Prazosin; Quinazolines; Receptors, Cell Surface; Receptors, Lipoprotein

1985
Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    British journal of pharmacology, 1985, Volume: 86, Issue:1

    Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Azepines; Blood Pressure; Doxazosin; Heart Rate; Hemodynamics; Kinetics; Male; Membranes; Muscle, Smooth, Vascular; Prazosin; Rats; Time Factors

1985
Alpha 1-adrenergic blockade raises epinephrine-arrhythmia threshold in halothane-anesthetized dogs in a dose-dependent fashion.
    Anesthesiology, 1985, Volume: 63, Issue:6

    Topics: Adrenergic alpha-Antagonists; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Doxazosin; Droperidol; Epinephrine; Halothane; Prazosin

1985
Clinical pharmacological studies with doxazosin.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aging; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Half-Life; Humans; Kinetics; Male; Prazosin

1986
The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Anesthesia; Angiotensin II; Animals; Antihypertensive Agents; Cats; Dogs; Doxazosin; Electric Stimulation; Heart; Hypertension, Renal; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nictitating Membrane; Prazosin; Rabbits; Species Specificity

1986
Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Cardiology, 1986, Volume: 73, Issue:3

    Topics: Adrenergic alpha-Antagonists; Age Factors; Animals; Antihypertensive Agents; Blood Pressure; Doxazosin; Humans; Hypertension; Lipids; Metabolic Clearance Rate; Prazosin; Protein Binding; Receptors, Adrenergic, alpha; Renin; Structure-Activity Relationship

1986
[Reduction of coronary risk factors with selective alpha-blockers. International Doxazosin Symposium. Frankfurt/Main, 7 June 1986].
    Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis, 1986, Volume: 8

    Topics: Adrenergic alpha-Antagonists; Coronary Disease; Doxazosin; Humans; Prazosin; Risk

1986
Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Disease Models, Animal; Doxazosin; Female; Hypercholesterolemia; Lipoproteins; Male; Mice; Mice, Inbred Strains; Prazosin

1987
Pharmacokinetic overview of doxazosin.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Biological Availability; Biotransformation; Doxazosin; Half-Life; Humans; Injections, Intravenous; Kinetics; Middle Aged; Prazosin

1987
Role of alpha 1- and alpha 2-adrenergic receptors in the human hypertensive kidney.
    Hypertension (Dallas, Tex. : 1979), 1987, Volume: 9, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Doxazosin; Humans; Hypertension; Kidney; Middle Aged; Prazosin; Receptors, Adrenergic, alpha; Renal Circulation; Renin; Yohimbine

1987
Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin.
    Xenobiotica; the fate of foreign compounds in biological systems, 1988, Volume: 18, Issue:1

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Biological Availability; Blood Pressure; Doxazosin; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Mathematics; Models, Biological; Prazosin

1988
alpha-Adrenoceptors and cold-induced vasoconstriction in human finger skin.
    The American journal of physiology, 1988, Volume: 255, Issue:5 Pt 2

    Topics: Adrenergic alpha-Agonists; Azepines; Cold Temperature; Doxazosin; Fingers; Humans; Male; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha; Regional Blood Flow; Skin; Vasoconstriction; Yohimbine

1988
Clinical experience with doxazosin in general medical practice.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Doxazosin; Family Practice; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Doxazosin; Family Practice; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapy.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Coronary Disease; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Risk Factors

1988
Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Doxazosin; Female; Heart Rate; Humans; Hypertension; Kidney Diseases; Lipids; Male; Middle Aged; Prazosin

1988
A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Diabetes Mellitus, Type 2; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Doxazosin; Drug Resistance; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Prazosin

1988
A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Coronary Disease; Doxazosin; Drug Resistance; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin

1988
Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin.
    Scandinavian journal of clinical and laboratory investigation, 1988, Volume: 48, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Chinchilla; Cholesterol; Doxazosin; Drug Evaluation, Preclinical; Female; Hypercholesterolemia; Lipids; Prazosin

1988
Doxazosin determination by high-performance liquid chromatography using fluorescence detection.
    Journal of chromatography, 1985, Nov-08, Volume: 344

    Topics: Antihypertensive Agents; Chromatography, High Pressure Liquid; Doxazosin; Humans; Prazosin; Spectrometry, Fluorescence

1985
Alpha 1-adrenoreceptor blockade in hypertension: pharmacological and clinical profile of doxazosin. Proceedings of an international symposium. Venice, Italy, 14 June 1985.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Animals; Antihypertensive Agents; Doxazosin; Humans; Hypertension; Prazosin

1986
The metabolism and kinetics of doxazosin in man, mouse, rat and dog.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adult; Animals; Antihypertensive Agents; Biological Availability; Blood Proteins; Body Fluids; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dogs; Doxazosin; Humans; Kinetics; Male; Mice; Prazosin; Protein Binding; Rats; Species Specificity

1986
Acute renal effects of doxazosin in man.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Doxazosin; Humans; Kidney; Male; Middle Aged; Physical Exertion; Prazosin; Renal Circulation; Renin

1986
Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Physical Exertion; Prazosin; Time Factors

1986
The pharmacokinetics of doxazosin in elderly normotensives.
    British journal of clinical pharmacology, 1986, Volume: 21, Issue:5

    Topics: Administration, Oral; Adult; Age Factors; Aged; Biological Availability; Blood Pressure; Doxazosin; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Prazosin

1986
Pharmacokinetics and effect on blood pressure of doxazosin in normal subjects and patients with renal failure.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:5

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Prazosin; Renal Dialysis

1986
A symposium: Doxazosin: coronary artery disease risk factor management. June 7, 1986, Frankfurt, Germany.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Antihypertensive Agents; Coronary Disease; Doxazosin; Humans; Hypertension; Prazosin; Risk

1987
[Doxazocin].
    Ugeskrift for laeger, 1988, Jul-25, Volume: 150, Issue:30

    Topics: Animals; Antihypertensive Agents; Doxazosin; Humans; Prazosin

1988
Doxazosin: A distinctive approach to risk reduction of coronary heart disease in hypertensive patients. Proceedings of a symposium. Hamburg, West Germany, January 30, 1988.
    American heart journal, 1988, Volume: 116, Issue:6 Pt 2

    Topics: Antihypertensive Agents; Coronary Disease; Doxazosin; Humans; Hypertension; Prazosin; Risk Factors

1988
Liquid chromatographic analysis of doxazosin in human serum with manual and robotic sample preparation.
    Journal of chromatographic science, 1988, Volume: 26, Issue:11

    Topics: Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Doxazosin; Humans; Prazosin; Robotics; Spectrometry, Fluorescence

1988
Effect of sympathetic stimulation and intrarenal alpha-blockade on the secretion of renin by the human kidney.
    European journal of clinical investigation, 1985, Volume: 15, Issue:4

    Topics: Adult; Doxazosin; Female; Hemodynamics; Humans; Hypertension; Isometric Contraction; Kidney; Male; Middle Aged; Phentolamine; Prazosin; Receptors, Adrenergic, alpha; Renal Circulation; Renin; Sympathetic Nervous System

1985
A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats.
    European journal of pharmacology, 1986, Oct-07, Volume: 129, Issue:3

    Topics: Action Potentials; Animals; Blood Pressure; Cats; Doxazosin; Male; Piperazines; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Vascular Resistance

1986
Effects of exogenous adrenaline and noradrenaline on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1984, Volume: 2, Issue:3

    Topics: Adult; Blood Vessels; Dose-Response Relationship, Drug; Doxazosin; Epinephrine; Forearm; Humans; Male; Norepinephrine; Prazosin; Receptors, Adrenergic, alpha; Regional Blood Flow; Sodium Chloride; Vasoconstriction; Vasodilator Agents; Yohimbine

1984
Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities.
    Archives internationales de pharmacodynamie et de therapie, 1980, Volume: 245, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Clonidine; Doxazosin; Heart Rate; Hemodynamics; Hexobarbital; Injections, Intraventricular; Male; Phenylephrine; Prazosin; Quinazolines; Rats

1980
Heterogeneity of post-junctional alpha-adrenoceptors in human vascular smooth muscle.
    Archives internationales de pharmacodynamie et de therapie, 1981, Volume: 254, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Prazosin; Receptors, Adrenergic; Receptors, Adrenergic, alpha

1981
Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin.
    British journal of pharmacology, 1983, Volume: 80, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Aorta; Calcium; Dose-Response Relationship, Drug; Doxazosin; In Vitro Techniques; Male; Norepinephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilator Agents

1983
Analysis of the pressor dose response.
    Clinical pharmacology and therapeutics, 1982, Volume: 32, Issue:4

    Topics: Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Drug Interactions; Epinephrine; Ethanolamines; Humans; Labetalol; Mathematics; Models, Biological; Norepinephrine; Prazosin; Pressoreceptors

1982
Effects of prazosin and two of its derivatives (UK 18.596 and UK 33.274) on alpha-adrenoceptors [proceedings].
    British journal of pharmacology, 1980, Volume: 68, Issue:1

    Topics: Animals; Cats; Doxazosin; Prazosin; Quinazolines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha

1980
Identification of vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man.
    Circulation research, 1984, Volume: 54, Issue:4

    Topics: Adult; Azepines; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Doxazosin; Female; Guanfacine; Guanidines; Heart Rate; Humans; Male; Methoxamine; Muscle, Smooth, Vascular; Phenylacetates; Prazosin; Receptors, Adrenergic, alpha; Receptors, Neurotransmitter; Yohimbine

1984
Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection.
    Journal of chromatography, 1980, Nov-14, Volume: 221, Issue:1

    Topics: Chromatography, High Pressure Liquid; Doxazosin; Humans; Hypotension; Prazosin; Quinazolines; Vasodilator Agents

1980
Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline.
    British journal of pharmacology, 1995, Volume: 115, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Aorta; Binding, Competitive; Dose-Response Relationship, Drug; Doxazosin; Male; Norepinephrine; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Vasodilation

1995
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Urology, 1994, Volume: 44, Issue:1

    Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin

1994
A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats.
    European journal of pharmacology, 1995, Dec-29, Volume: 294, Issue:2-3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Blood Pressure; Cats; Doxazosin; Heart Rate; Male; Prazosin; Sympathetic Nervous System; Urinary Bladder

1995
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    British journal of pharmacology, 1996, Volume: 118, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Pressure; Prostate; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

1996
Alpha-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:4

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Female; Humans; Prazosin; Prevalence; Urinary Incontinence

1996
The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
    European journal of pharmacology, 1996, Oct-10, Volume: 313, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Binding Sites; Binding, Competitive; Cell Line; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Phenethylamines; Prazosin; Prostate; Radioligand Assay; Receptors, Adrenergic, alpha; Stereoisomerism; Tetralones

1996
Pharmacological evaluation of prazosin- and doxazosin-related compounds with modified piperazine ring.
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:11

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Doxazosin; In Vitro Techniques; Injections, Intraperitoneal; Intubation, Gastrointestinal; Male; Muscle Contraction; Muscle, Smooth; Prazosin; Rats; Rats, Inbred SHR

1996
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs.
    Pharmacology, 1996, Volume: 53, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Doxazosin; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethra

1996
Alpha 1-adrenergic blockers: do they have a place in the prophylaxis of migraine?
    Headache, 1997, Volume: 37, Issue:2

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Child; Doxazosin; Female; Humans; Male; Middle Aged; Migraine Disorders; Prazosin

1997
The treatment of benign prostatic hyperplasia with alpha blockers in men over the age of 80 years.
    British journal of urology, 1997, Volume: 80, Issue:6

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Blood Pressure; Doxazosin; Humans; Male; Prazosin; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urination

1997
Alpha-adrenergic receptors regulate human lymphocyte amiloride-sensitive sodium channels.
    The American journal of physiology, 1998, Volume: 275, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amiloride; Animals; Cell Transformation, Viral; Cells, Cultured; Cyclic AMP; Doxazosin; Endothelium, Vascular; Epithelial Sodium Channels; GTP-Binding Proteins; Herpesvirus 4, Human; Humans; Isoproterenol; Membrane Potentials; Norepinephrine; Patch-Clamp Techniques; Prazosin; Rats; Receptors, Adrenergic, alpha; Recombinant Proteins; Second Messenger Systems; Sodium Channels; Thionucleotides; Transcription, Genetic

1998
Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
    Journal of Korean medical science, 1999, Volume: 14, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Prazosin; Rabbits; Sulfonamides; Tamsulosin

1999
Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    The Journal of urology, 1999, Volume: 161, Issue:6

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Apoptosis; Cell Division; Doxazosin; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Retrospective Studies

1999
Doxazosin-to-terazosin switch for benign prostatic hyperplasia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999, Jul-01, Volume: 56, Issue:13

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Doxazosin; Drug Prescriptions; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; United States; United States Department of Veterans Affairs

1999
Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes.
    British journal of pharmacology, 2000, Volume: 129, Issue:7

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Azepines; Brimonidine Tartrate; Cell Line; Cricetinae; Dexmedetomidine; Dose-Response Relationship, Drug; Doxazosin; Gene Expression; Humans; Hydrogen-Ion Concentration; Imidazoles; Norepinephrine; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Tetrahydronaphthalenes; Yohimbine

2000
Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
    British journal of pharmacology, 2000, Volume: 129, Issue:7

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aniline Compounds; Animals; Azepines; Binding, Competitive; Brimonidine Tartrate; Calcium; Cell Line; Cricetinae; Dexmedetomidine; Dose-Response Relationship, Drug; Doxazosin; Estrenes; Fluorescence; Gene Expression; Humans; Imidazoles; Norepinephrine; Prazosin; Pyrrolidinones; Quinoxalines; Radioligand Assay; Receptor Cross-Talk; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Signal Transduction; Tetrahydronaphthalenes; Thapsigargin; Xanthenes; Yohimbine

2000
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Cancer research, 2000, Aug-15, Volume: 60, Issue:16

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cells, Cultured; Doxazosin; Growth Inhibitors; Humans; Male; Mice; Mice, SCID; Muscle, Smooth; Neoplasm Transplantation; Prazosin; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tamsulosin; Transplantation, Heterologous

2000
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    The Prostate. Supplement, 2000, Volume: 9

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin

2000
Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists.
    Southern medical journal, 2000, Volume: 93, Issue:12

    Topics: Adrenergic alpha-Antagonists; Aged; Comorbidity; Doxazosin; Humans; Louisiana; Male; Postoperative Complications; Prazosin; Prostatic Hyperplasia; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Transurethral Resection of Prostate; Treatment Failure; Treatment Outcome; Urologic Diseases

2000
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium

2001
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens

2001
Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.
    Clinical therapeutics, 2001, Volume: 23, Issue:5

    Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Diarrhea; Dizziness; Doxazosin; Drug Therapy, Combination; Fractures, Bone; Heart Diseases; Humans; Hypertension; Hypotension; Male; Neoplasms; Prazosin; Prostatic Hyperplasia; Retrospective Studies; Stroke; Syncope

2001
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Cancer research, 2002, Jan-15, Volume: 62, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured

2002
Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.
    Urologia internationalis, 2002, Volume: 69, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Retrospective Studies

2002
Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.
    Circulation, 2003, Jan-07, Volume: 107, Issue:1

    Topics: 3T3 Cells; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Calcineurin Inhibitors; Cell Survival; Cells, Cultured; Doxazosin; Heart; Humans; Mice; Myocardium; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley

2003
Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    The Journal of urology, 2003, Volume: 169, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anoikis; Cell Adhesion; Cell Survival; Doxazosin; Endothelial Growth Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neoplasm Invasiveness; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tamsulosin; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
[Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Molecular Structure; Prazosin; Quinazolines

2002
Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions.
    Journal of pharmaceutical and biomedical analysis, 2004, Jan-27, Volume: 34, Issue:1

    Topics: Chromatography, High Pressure Liquid; Doxazosin; Prazosin; Reproducibility of Results; Stress, Mechanical

2004
Herbal and vitamin supplement use in a prostate cancer screening population.
    Urology, 2004, Volume: 63, Issue:2

    Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins

2004
A current review of medical therapy for benign prostatic hyperplasia.
    The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders

2004
Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 369, Issue:5

    Topics: Adrenergic alpha-Antagonists; Animals; Apoptosis; Cells, Cultured; Doxazosin; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Prazosin; Xenopus

2004
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics

2004
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
    Ophthalmology, 2005, Volume: 112, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2005
In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Doxazosin; Male; Prazosin; Pupil; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Time Factors; Urethra

2006
alpha-blocker treatment of urolithiasis.
    European urology, 2006, Volume: 50, Issue:2

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Therapy, Combination; Glucocorticoids; Humans; Prazosin; Sulfonamides; Tamsulosin; Urolithiasis

2006
The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats.
    Current eye research, 2007, Volume: 32, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; Iris; Male; Prazosin; Pupil; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin

2007
Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.
    The Journal of urology, 2007, Volume: 178, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Doxazosin; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prazosin; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome; United States

2007
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.
    European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Aged; Dose-Response Relationship, Drug; Doxazosin; Epididymis; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Norepinephrine; Organ Specificity; Prazosin; Prostate; Quinazolines; Stimulation, Chemical; Vas Deferens

2007
alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Acetaminophen; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxazosin; Erythrocytes; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Liver; Liver Circulation; Liver Diseases; Male; Membrane Proteins; Mice; Prazosin; Protein Binding; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Time Factors; Transaminases

2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
    Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2008
Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2009, Volume: 45, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cricetinae; Doxazosin; Indoles; Male; Mesocricetus; Mice; Mice, Inbred ICR; Muscle Contraction; Norepinephrine; Prazosin; Quinazolines; Ureter

2009
Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
    Oncology research, 2009, Volume: 17, Issue:11-12

    Topics: Adrenergic alpha-Antagonists; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Daunorubicin; Digoxin; Doxazosin; Drug Resistance, Multiple; HeLa Cells; Humans; Neoplasm Proteins; Prazosin; Vinblastine

2009
Pheochromocytoma in children and adolescents.
    Indian journal of pediatrics, 2009, Volume: 76, Issue:11

    Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-Antagonists; Child; Doxazosin; Female; Humans; Hypertension; Intraoperative Complications; Male; Pheochromocytoma; Prazosin; Treatment Outcome

2009
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    The Journal of urology, 2010, Volume: 183, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin

2010
Enantioselective determination of doxazosin in human plasma by liquid chromatography-tandem mass spectrometry using ovomucoid chiral stationary phase.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010, Sep-15, Volume: 878, Issue:26

    Topics: Adrenergic alpha-1 Receptor Antagonists; Chromatography, Liquid; Doxazosin; Drug Stability; Humans; Least-Squares Analysis; Ovomucin; Prazosin; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Tandem Mass Spectrometry

2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.
    Urology, 2011, Volume: 77, Issue:6

    Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography

2011
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.
    Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

2011
Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.
    Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:8

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cohort Studies; Doxazosin; Drug Combinations; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prazosin; Predictive Value of Tests; Prospective Studies; Pupil; Risk Factors; Sensitivity and Specificity; Sulfonamides; Syndrome; Tamsulosin; Tropicamide

2011
Revelation on the potency of α(1) -blockers - parallel blockade of angiotensin II receptor: a new finding.
    Pharmaceutical biology, 2012, Volume: 50, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Dose-Response Relationship, Drug; Doxazosin; Imidazoles; In Vitro Techniques; Losartan; Male; Molecular Structure; Prazosin; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Tetrazoles; Valine; Valsartan; Vasodilation; Vasodilator Agents

2012
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.
    Journal of pharmacy practice, 2012, Volume: 25, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin

2012
Rapid and sensitive online determination of some selective α1-blockers by flow injection analysis with micelle-enhanced fluorescence detection.
    Journal of fluorescence, 2013, Volume: 23, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Flow Injection Analysis; Fluorescence; Internet; Micelles; Prazosin; Quinazolines; Spectrometry, Fluorescence; Time Factors

2013
Rayleigh light scattering detection of three α1-adrenoceptor antagonists coupled with high performance liquid chromatograph.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Aug-05, Volume: 147

    Topics: Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Dimerization; Doxazosin; Dynamic Light Scattering; Humans; Hydrogen Bonding; Limit of Detection; Models, Molecular; Prazosin

2015
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
    The Canadian journal of urology, 2015, Volume: 22, Issue:4

    Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate

2015
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    The Prostate, 2016, Volume: 76, Issue:8

    Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin

2016
Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in rats.
    Psychopharmacology, 2016, Volume: 233, Issue:11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Alcohol Drinking; Animals; Brain Chemistry; Doxazosin; Extinction, Psychological; Genes, fos; Injections, Intraventricular; Male; Prazosin; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self Administration; Yohimbine

2016
An efficient spectrofluorimetric method adopts doxazosin, terazosin and alfuzosin coupling with orthophthalaldehyde: Application in human plasma.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018, Apr-15, Volume: 195

    Topics: Doxazosin; Fluorescence; Humans; Limit of Detection; o-Phthalaldehyde; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence

2018
[Quantification of (-)doxazosin at very low concentration in rat plasma samples by SPE-LC-MS/MS].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:7

    Topics: Administration, Intravenous; Animals; Chromatography, Liquid; Doxazosin; Plasma; Prazosin; Rats; Sensitivity and Specificity; Solid Phase Extraction; Stereoisomerism; Tandem Mass Spectrometry

2016
Micellar enhanced spectrofluorimetric approach for nanogram detection of certain α
    Luminescence : the journal of biological and chemical luminescence, 2018, Volume: 33, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Doxazosin; Fluorescence; Humans; Limit of Detection; Micelles; Pharmaceutical Preparations; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence; Tablets

2018
Evaluation of syncope association with α
    Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin

2019
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.
    JAMA neurology, 2021, 04-01, Volume: 78, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States

2021
A Concise and Useful Guide to Understand How Alpha
    Mini reviews in medicinal chemistry, 2022, Volume: 22, Issue:18

    Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Doxazosin; Epinephrine; Norepinephrine; Prazosin; Receptors, Adrenergic, alpha-1

2022
6-nitrodopamine is a major endogenous modulator of human vas deferens contractility.
    Andrology, 2022, Volume: 10, Issue:8

    Topics: Adrenergic Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Chromatography, Liquid; Desipramine; Dopamine; Doxazosin; Epinephrine; Humans; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Prazosin; Rats; Receptors, Adrenergic; Tamsulosin; Tandem Mass Spectrometry; Vas Deferens

2022
Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance.
    Minerva urology and nephrology, 2023, Volume: 75, Issue:4

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Hypotension, Orthostatic; Prazosin; Tamsulosin; Urogenital Diseases

2023